3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
19
Esophageal Squamous Cell Carcinoma
5
Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Rectal Neoplasms
3
Head and Neck Neoplasms
3
Carcinoma, Hepatocellular
3
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Ovarian Neoplasms
2
Neoplasm, Residual
2
Neoplasm Metastasis
2
Lymphoma, Large B-Cell, Diffuse
2
Lung Neoplasms
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Waldenstrom Macroglobulinemia
1
Urinary Bladder Neoplasms
1
Turcot syndrome
1
Testicular Neoplasms
1
Surgery
1
Stress, Psychological
1
Squamous Cell Carcinoma of External Auditory Canal
1
Solitary Fibrous Tumor, Pleural
1
Seminoma
1
Recurrence
1
Postoperative Complications
1
Interventions
Nivolumab
6
Ipilimumab
2
Gemcitabine
2
zaleplon
1
temsirolimus
1
relatlimab
1
regorafenib
1
olaparib
1
linrodostat
1
Vorinostat
1
Trastuzumab
1
Standard of Care
1
Sirolimus
1
Rehabilitation
1
Psychotherapy
1
Paclitaxel
1
Oxaliplatin
1
Niacin
1
IFL protocol
1
Health Services Needs and Demand
1
Everolimus
1
Clinical Trials, Phase IV as Topic
1
Cisplatin
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Cancer
×
Neoadjuvant Therapy
×
1 year
×
Clear all
No trials found.